Compare IPSC & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | TBI |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.0M | 311.4M |
| IPO Year | 2021 | 1995 |
| Metric | IPSC | TBI |
|---|---|---|
| Price | $1.44 | $8.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $4.75 | ★ $9.75 |
| AVG Volume (30 Days) | ★ 690.4K | 229.0K |
| Earning Date | 11-12-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | 61.39 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $8.10 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $3.18 |
| 52 Week High | $2.97 | $11.03 |
| Indicator | IPSC | TBI |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 41.59 |
| Support Level | $0.90 | $8.63 |
| Resistance Level | $2.62 | $8.90 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 31.43 | 8.51 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.